Clinical Trials on PIK3CA-related Overgrowth Spectrum in Netherlands

Total 8 results

Novartis Pharmaceuticals

Recruiting

Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (EPIK-P2)

PIK3CA-related Overgrowth Spectrum (PROS)

United States, Canada, Spain, Switzerland, France, United Kingdom, Germany, Italy, China, Hong Kong, Netherlands, Norway
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Family Motivational Intervention in Schizophrenia (FMI)

Schizophrenia | Cannabis

Netherlands
Erasmus Medical Center
Utrecht University

Unknown

Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex (RAPIT)

Tuberous Sclerosis Complex | TSC Related Cognitive Disability | TSC Related Autism | TSC Related Learning Problems

Netherlands
Iris Sommer

Unknown

Transcranial Direct Current Stimulation as Treatment for Auditory Hallucinations (tDCS)

Personality Disorders | Psychotic Disorders | Mood Disorders | Stress Disorders, Post-Traumatic | Hearing Disorders

Netherlands
AstraZeneca

Completed

A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine) (SEQUEL)

Schizophrenia | Bipolar Disorder

Netherlands
Eli Lilly and Company

Completed

Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States, Puerto Rico, Netherlands, Canada, Mexico
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Schizophrenia | Bipolar Disorder | Autistic Disorder | Conduct and Other Disruptive Behavior Disorders

United States, Belgium, Germany, Poland, Greece, Netherlands
AstraZeneca

Active, not recruiting

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Cervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 Positive

United States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore

Clinical Trials on PIK3CA-related Overgrowth Spectrum in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations